Bridgewater Advisors Inc. Makes New $704,000 Investment in Globe Life Inc. $GL

Bridgewater Advisors Inc. bought a new position in Globe Life Inc. (NYSE:GLFree Report) in the 2nd quarter, HoldingsChannel.com reports. The institutional investor bought 3,827 shares of the company’s stock, valued at approximately $704,000.

Other large investors have also recently modified their holdings of the company. CYBER HORNET ETFs LLC purchased a new position in shares of Globe Life during the second quarter valued at about $28,000. Hilton Head Capital Partners LLC purchased a new stake in Globe Life in the fourth quarter worth about $30,000. MUFG Securities EMEA plc purchased a new stake in Globe Life in the second quarter worth about $31,000. Torren Management LLC bought a new stake in Globe Life during the 4th quarter valued at approximately $37,000. Finally, AdvisorNet Financial Inc boosted its position in Globe Life by 41.1% during the 1st quarter. AdvisorNet Financial Inc now owns 316 shares of the company’s stock valued at $44,000 after acquiring an additional 92 shares in the last quarter. Institutional investors own 81.61% of the company’s stock.

Globe Life Trading Up 0.1%

Shares of NYSE GL opened at $180.87 on Friday. Globe Life Inc. has a 1 year low of $127.85 and a 1 year high of $191.55. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.07 and a quick ratio of 0.07. The firm has a 50-day moving average of $177.16 and a 200 day moving average of $157.27. The stock has a market cap of $13.90 billion, a P/E ratio of 12.01 and a beta of 0.48.

Globe Life (NYSE:GLGet Free Report) last announced its quarterly earnings data on Wednesday, July 22nd. The company reported $3.61 earnings per share for the quarter, missing analysts’ consensus estimates of $3.67 by ($0.06). The business had revenue of $1.60 billion during the quarter, compared to analysts’ expectations of $1.59 billion. Globe Life had a return on equity of 20.52% and a net margin of 19.58%.Globe Life’s revenue for the quarter was up 8.0% compared to the same quarter last year. During the same quarter last year, the company posted $3.05 EPS. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. As a group, sell-side analysts expect that Globe Life Inc. will post 15.71 EPS for the current fiscal year.

Globe Life Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Monday, October 5th will be given a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Monday, October 5th. Globe Life’s payout ratio is currently 8.76%.

Globe Life declared that its board has initiated a stock repurchase program on Monday, August 10th that authorizes the company to repurchase $2.50 billion in shares. This repurchase authorization authorizes the company to buy up to 17.7% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company’s board of directors believes its shares are undervalued.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the company. Truist Financial upped their target price on Globe Life from $180.00 to $185.00 and gave the stock a “buy” rating in a report on Friday, April 24th. Keefe, Bruyette & Woods lowered their target price on Globe Life from $192.00 to $190.00 and set an “outperform” rating for the company in a research note on Friday, July 24th. TD Cowen lifted their price target on Globe Life from $215.00 to $225.00 and gave the company a “buy” rating in a research report on Wednesday, July 22nd. Wells Fargo & Company upped their price target on Globe Life from $172.00 to $193.00 and gave the stock an “overweight” rating in a research note on Thursday, July 9th. Finally, Morgan Stanley increased their price objective on Globe Life from $181.00 to $208.00 and gave the stock an “overweight” rating in a report on Monday, July 6th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Globe Life presently has a consensus rating of “Moderate Buy” and an average target price of $191.67.

Get Our Latest Analysis on Globe Life

Insider Transactions at Globe Life

In other Globe Life news, EVP Michael Clay Majors sold 37,000 shares of Globe Life stock in a transaction on Wednesday, July 29th. The stock was sold at an average price of $178.64, for a total transaction of $6,609,680.00. Following the completion of the transaction, the executive vice president owned 53,518 shares in the company, valued at approximately $9,560,455.52. The trade was a 40.88% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Thomas Peter Kalmbach sold 21,000 shares of the business’s stock in a transaction on Thursday, July 30th. The stock was sold at an average price of $180.06, for a total value of $3,781,260.00. Following the completion of the sale, the chief financial officer directly owned 50,568 shares in the company, valued at $9,105,274.08. This trade represents a 29.34% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 191,747 shares of company stock worth $33,480,408. Company insiders own 2.11% of the company’s stock.

Globe Life Profile

(Free Report)

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.

Recommended Stories

Want to see what other hedge funds are holding GL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Globe Life Inc. (NYSE:GLFree Report).

Institutional Ownership by Quarter for Globe Life (NYSE:GL)

Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.